Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin beta 3 class III pseudogene 1 (TUBB3P1) is a pseudogene, meaning it shares sequence similarity with the protein-coding gene TUBB3 but contains mutations or deletions that prevent it from encoding the neurally expressed βIII-tubulin protein. While some pseudogenes can play regulatory roles in gene expression, such effects for TUBB3P1 have not been described. Because it cannot produce a functional protein, TUBB3P1 is not considered a drug target, receptor, enzyme, transporter, or biomarker. Information about βIII-tubulin (TUBB3) and its roles in microtubule dynamics, neurogenesis, cancer, and drug resistance is widely available, but these functions do not apply to TUBB3P1, which is a non-coding pseudogene. Key clarification: The name TUBB3P1 can be confused with TUBB3 (the functional gene). Drug targeting, biological function, and disease roles described for βIII-tubulin (TUBB3) are not relevant to TUBB3P1. For drug discovery and therapeutic literature, only the functional TUBB3 (not pseudogene TUBB3P1) is considered actionable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin beta 3 class III pseudogene 1 (TUBB3P1).